Pharmaceutical companies—including Eli Lilly and Novo Nordisk, which currently dominate the obesity market—have been testing ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Pharmaceutical giant Eli Lilly (LLY) has promised to make its new weight-loss pill in the U.S. as President Donald Trump ...

If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Most U.S. stocks rose, but the worst drop for UnitedHealth Group in a quarter century kept Wall Street in check.

U.S. stocks saw mixed movements as UnitedHealth plunged 22% after a weak earnings report, dragging the Dow down 527 points.

The S&P 500 rose 0.13% to close at 5,282.70 on Thursday (April 17) after a volatile trading session, though the index still ...

Most U.S. stocks rose, but the worst drop for UnitedHealth Group in a quarter of a century kept Wall Street in check. The S&P 500 edged up 0.1% Thursday even ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.